Low dose pig anti-influenza virus monoclonal antibodies reduce lung pathology but do not prevent virus shedding
B. Paudyal, A. McNee, P. Rijal, B. V. Carr, A. Nunez, J. W. McCauley, R. S. Daniels, A. R. Townsend, J. A. Hammond, E. Tchilian
This study shows that high-dose pig monoclonal antibodies reduce lung pathology and virus load but not nasal shedding, suggesting lower doses may suffice for disease severity reduction.
bioRxiv · Oct 8, 2021Immunology